Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guilhem Roubaud

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
La Revue Du Praticien|January 23, 2026
[Living with… testicular cancer]Guilhem Roubaud, Karim Fizazi
Andrology|May 9, 2024
The testosterone replacement therapy for prostate cancer patients: Time to take the leap?Jennifer Le Guevelou, Guillaume Ploussard, Guilhem Roubaud, et al.
Current Opinion in Urology|September 19, 2025
Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancerRomain Iaxx, Diego Teyssonneau, Catherine Fallaha, et al.
Nature Reviews. Clinical Oncology|November 23, 2016
Strategies to avoid treatment-induced lineage crisis in advanced prostate cancerGuilhem Roubaud, Bobby C Liaw, William K Oh, et al.
World Journal of Urology|December 17, 2022
Chromogranin A: a useful biomarker in castration-resistant prostate cancerGuillaume Ploussard, François Rozet, Guilhem Roubaud, et al.
Seminars in Interventional Radiology|November 8, 2018
Image-Guided Bone Consolidation in OncologyXavier Buy, Vittorio Catena, Guilhem Roubaud, et al.
Future Oncology (London, England)|December 5, 2014
Long clinical benefit achieved in two patients with malignant paraganglioma treated by metronomic cyclophosphamidePauline Gillon, Yann Godbert, Charles Dupin, et al.
Bulletin Du Cancer|March 22, 2017
[Image-guided bone consolidation in oncology: Cementoplasty and percutaneous screw fixation]Xavier Buy, Roberto Luigi Cazzato, Vittorio Catena, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 1, 2006
[Bone metastatic evolution of a recurrent meningioma: case report]Helène Tournat, Aymeri Huchet, Nora Ouhabrache, et al.
Bulletin Du Cancer|July 1, 2014
[Revision of therapeutic index for targeted treatment in kidney cancer: What if toxicity could predict efficacy?]Thomas Grellety, Camille Brugères-Chakiba, Axel Chaminade, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
La Revue Du Praticien|January 23, 2026
[Living with… testicular cancer]Guilhem Roubaud, Karim Fizazi
Andrology|May 9, 2024
The testosterone replacement therapy for prostate cancer patients: Time to take the leap?Jennifer Le Guevelou, Guillaume Ploussard, Guilhem Roubaud, et al.
Current Opinion in Urology|September 19, 2025
Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancerRomain Iaxx, Diego Teyssonneau, Catherine Fallaha, et al.
Nature Reviews. Clinical Oncology|November 23, 2016
Strategies to avoid treatment-induced lineage crisis in advanced prostate cancerGuilhem Roubaud, Bobby C Liaw, William K Oh, et al.
World Journal of Urology|December 17, 2022
Chromogranin A: a useful biomarker in castration-resistant prostate cancerGuillaume Ploussard, François Rozet, Guilhem Roubaud, et al.
Seminars in Interventional Radiology|November 8, 2018
Image-Guided Bone Consolidation in OncologyXavier Buy, Vittorio Catena, Guilhem Roubaud, et al.
Future Oncology (London, England)|December 5, 2014
Long clinical benefit achieved in two patients with malignant paraganglioma treated by metronomic cyclophosphamidePauline Gillon, Yann Godbert, Charles Dupin, et al.
Bulletin Du Cancer|March 22, 2017
[Image-guided bone consolidation in oncology: Cementoplasty and percutaneous screw fixation]Xavier Buy, Roberto Luigi Cazzato, Vittorio Catena, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 1, 2006
[Bone metastatic evolution of a recurrent meningioma: case report]Helène Tournat, Aymeri Huchet, Nora Ouhabrache, et al.
Bulletin Du Cancer|July 1, 2014
[Revision of therapeutic index for targeted treatment in kidney cancer: What if toxicity could predict efficacy?]Thomas Grellety, Camille Brugères-Chakiba, Axel Chaminade, et al.
Pageof 10